There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Phreesia (PHR – Research Report), Braze (BRZE – Research Report) and UiPath (PATH – Research Report) with bullish sentiments.
Phreesia (PHR)
In a report released today, Joe Goodwin from JMP Securities maintained a Buy rating on Phreesia, with a price target of $50.00. The company’s shares closed last Wednesday at $29.38, close to its 52-week low of $22.89.
According to TipRanks.com, Goodwin is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Phreesia has an analyst consensus of Moderate Buy, with a price target consensus of $55.00, which is an 87.2% upside from current levels. In a report issued on March 28, Jefferies also maintained a Buy rating on the stock with a $59.00 price target.
See the top stocks recommended by analysts >>
Braze (BRZE)
In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Braze, with a price target of $90.00. The company’s shares closed last Wednesday at $43.58.
According to TipRanks.com, Walravens is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Braze with a $77.00 average price target, which is a 60.7% upside from current levels. In a report released today, Oppenheimer also maintained a Buy rating on the stock with a $60.00 price target.
UiPath (PATH)
Oppenheimer analyst Brian Schwartz maintained a Buy rating on UiPath today and set a price target of $35.00. The company’s shares closed last Wednesday at $29.04, close to its 52-week low of $23.93.
According to TipRanks.com, Schwartz is a top 25 analyst with an average return of
UiPath has an analyst consensus of Moderate Buy, with a price target consensus of $48.86.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PHR:
